Detalhe da pesquisa
1.
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Br J Cancer
; 130(5): 777-787, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191609
2.
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.
Int J Mol Sci
; 24(1)2023 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614248
3.
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Gastric Cancer
; 24(4): 926-936, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651195
4.
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Gastric Cancer
; 24(2): 445-456, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970266
5.
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
Br J Cancer
; 117(6): 775-782, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28765618
6.
Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis.
Clin Chim Acta
; 557: 117895, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561063
7.
Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal Cancer.
Cancers (Basel)
; 16(5)2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473321
8.
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.
Cancers (Basel)
; 15(17)2023 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686682
9.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Ther Adv Med Oncol
; 15: 17588359231157641, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895850
10.
Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy.
J Clin Med
; 11(20)2022 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36294412
11.
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Ther Adv Med Oncol
; 13: 17588359211019672, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211587
12.
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
PLoS One
; 15(7): e0235848, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735623
13.
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Thromb Haemost
; 119(11): 1849-1859, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31461750
14.
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Eur J Surg Oncol
; 44(8): 1191-1198, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685755
15.
Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.
PLoS One
; 10(4): e0124239, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25874698
16.
[Uneasiness or uncomfortably: is it a symptom ovenproof in the end of life?]. / Desasosiego o "disconfortabilidad": ¿un síntoma refractario en la fase final de la vida?
Med Clin (Barc)
; 132(17): 669-70, 2009 May 09.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19386328
17.
Desasosiego o "disconfortabilidad": ¿un síntoma refractario en la fase final de la vida? / Uneasiness or uncomfortably: Is it a symptom ovenproof in the end of life?
Med. clín (Ed. impr.)
; 132(17): 669-670, mayo 2009.
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-60640